Showing results (471-480 of 613) with videos related to
Sort By:
Pageof 62
JACC. Cardiovascular Interventions|March 6, 2017
Identification of Coronary Artery Side Branch Supplying Myocardial Mass That May Benefit From RevascularizationHyung Yoon Kim, Joon-Hyung Doh, Hong-Seok Lim, et al.International Journal of Cardiology|March 10, 2007
Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stentHack-Lyoung Kim, Kyung-Woo Park, Jae-Jin Kwak, et al.International Journal of Cardiology|November 9, 2011
Comparison between zotarolimus-eluting stents and first generation drug-eluting stents in the treatment of patients with acute ST-segment elevation myocardial infarctionKyung Woo Park, Woo-Hyun Lim, Ji-Hyun Kim, et al.Heart (British Cardiac Society)|September 22, 2011
Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registryHyeon-Cheol Gwon, Joo-Yong Hahn, Bon-Kwon Koo, et al.JACC. Asia|December 29, 2023
Prognostic Implications of Individual and Combinations of Resting and Hyperemic Coronary Pressure and Flow ParametersSeokhun Yang, Doyeon Hwang, Joo Myung Lee, et al.Journal of the American Heart Association|April 21, 2020
Prognostic Implications of Resistive Reserve Ratio in Patients With Coronary Artery DiseaseSeung Hun Lee, Joo Myung Lee, Jonghanne Park, et al.European Heart Journal|March 13, 2012
Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis (Mini-COREA) trial: celecoxib, a double-edged sword for patients with anginaHyun-Jae Kang, Il-Young Oh, Jin-Wook Chung, et al.Circulation|July 6, 2006
Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trialHyun-Jae Kang, Hae-Young Lee, Sang-Hoon Na, et al.JACC. Cardiovascular Interventions|May 24, 2014
Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitusKyung Woo Park, Joo Myung Lee, Si-Hyuck Kang, et al.Thrombosis and Haemostasis|January 1, 2019
Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTsJeehoon Kang, Kyung Woo Park, Tullio Palmerini, et al.Pageof 62